The thesis
SilentDip rests on a clean behavioural idea: a sharp drop with no negative headline is usually noise, and noise reverts. A sharp drop with genuine bad news tends to keep drifting lower. So the strategy only buys names that are technically oversold and show no salient negative sentiment, then exits as price mean-reverts toward its SMA20 or RSI normalizes.
The idea is grounded, not improvised. It is sourced from Clinch, He, Landsman & Li (SSRN working paper, Nov 2025), which extends Chan's 2003 work on price reactions to news versus no-news. That lineage matters: the no-news/bad-news asymmetry is one of the more durable findings in the delayed-reaction literature.
Recent activity
SilentDip went live on 2026-10-11, deployed with $10,000. The first run executed zero trades — it is holding full cash and simply waiting for a qualifying setup. That is expected for a selective, condition-gated strategy, but it does mean there is no live track record yet to confirm the backtest.
The automated reviewer approved it at a low risk score of 0.32, calling it a "safe mean-reversion strategy" that respects cash, max-position, and max-position-count limits. Two caveats were flagged and worth keeping on the watchlist: a missing non-zero-price guard, and a budget-versus-equity sizing nuance. Neither is fatal, but both are the kind of edge case that only bites in live conditions.
Backtest and validation
Over 1,279 days the backtest returned 52.62% (final equity $15,262), a 8.69% CAGR, Sharpe 1.03, and a contained 10.38% max drawdown. Win rate is a high 70.55% across 294 trades — consistent with a strategy that books many small reversions.
The validation is the strongest part of the story. All four walk-forward folds were positive, with out-of-sample return of 16.75% and OOS Sharpe of 1.91. The probabilistic Sharpe ratio is 0.991, and the deflated Sharpe — which penalises the 42 trials run — still clears at 0.563. That the DSR survives multiple-testing deflation is a genuine point in its favour.
The risks
Balance demands scrutiny of where the returns came from. Folds 1 and 2 (spanning 2021–2024) were nearly flat at 4.96% and 1.91%, with Sharpes around 0.35. Almost all the strength sits in folds 3 and 4 (26.26% and 16.75%). The recent regime has been kind to this approach; a return to the choppier 2022-style conditions could revert it to break-even.
Turnover is also very high at 4,192%, so the edge must survive frequent trading and fee drag. And the 8.69% CAGR, while steady, is modest for a single-name equity strategy. SilentDip looks well-constructed and honestly validated — but it needs live trades and a tougher tape before we call the edge proven.